Biotech | November 12, 2021
Ronapreve gets the green light from CHMP to treat non-hospitalised Covid-19 patients
A final decision regarding the approval of Ronapreve is expected from the European Commission shortly
A final decision regarding the approval of Ronapreve is expected from the European Commission shortly
The centre has an initial capacity of 500 FTEs
Covaxin is the only Covid-19 vaccine to have demonstrated efficacy data from phase III clinical trials against the Delta variant at 65.2%
J. B. Chemicals & Pharmaceuticals Limited (JBCPL), announced its financial results for the second quarter ended 30th September, 2021
The company will provide the technical and financial resources to support the study
Sudeep Nutrition will be a one-stop solution for food, beverage, nutraceuticals and nutritional product manufacturers
LSDCheck is CE-IVD approved LCMSMS-based testing kit for LSD in newborns
Shaan’s hit song `Tanha Dil Tanha Safar relaunched
Cipla Technologies a subsidiary of Cipla and Pulmatrix had inked a definitive agreement for the co-development and commercialisation of Pulmazole.
It was recognized for its holistic initiatives designed to improve the quality of life and standards of care for patients
Subscribe To Our Newsletter & Stay Updated
